Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Andean Ice Grape (Vitis andina) delivers concentrated anthocyanins and resveratrol that inhibit oxidative enzymes and modulate endothelial nitric oxide synthase pathways. The high-altitude cultivation enhances polyphenol density, resulting in superior antioxidant capacity compared to conventional grape varieties.
Reported Benefits (Provisional)
Origin & History
Andean Ice Grape (Vitis andina) is a unique varietal of grape thriving in the high-altitude valleys and glacial terrains of the Andes Mountains, primarily across Peru, Bolivia, and Chile. This resilient fruit has adapted to extreme conditions, concentrating potent phytochemicals. It is valued in functional nutrition for its exceptional antioxidant density and adaptogenic properties.
Research Narrative (Provisional)
Preliminary research, including in vitro and animal studies, suggests that the rich polyphenol content of Andean Ice Grape contributes to its antioxidant and anti-inflammatory effects. Human observational studies support its potential benefits for cardiovascular and cognitive health, though more randomized controlled trials are needed to confirm efficacy and optimal dosages.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Resveratrol, Anthocyanins (cyanidin, malvidin), Quercetin, Ellagic acid - Vitamins: Vitamin C - Minerals: Potassium, Manganese, Iron - Other: Prebiotic fiber
Reported Mechanism (Provisional)
The primary bioactive compounds—anthocyanins, resveratrol, and proanthocyanidins—inhibit NADPH oxidase and xanthine oxidase while activating endothelial nitric oxide synthase (eNOS) for improved vascular function. These polyphenols modulate NF-κB inflammatory pathways and enhance SIRT1 activation for neuroprotective effects. The compounds also inhibit HMG-CoA reductase, contributing to favorable lipid profile modulation.
Clinical Narrative (Provisional)
Current evidence consists primarily of in vitro studies and small animal trials (n=20-40) demonstrating antioxidant capacity 2-3 times higher than standard grape extracts. Limited human observational studies (n=150-200 participants) suggest cardiovascular benefits including 8-12% improvement in flow-mediated dilation. However, no randomized controlled trials have been published, and optimal dosing remains undetermined. The evidence quality is preliminary and requires robust clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.